The role of UCH-L1, MMP-9, and GFAP as peripheral markers of different susceptibility to seizure development in a preclinical model of epilepsy

J Neuroimmunol. 2019 Jul 15:332:57-63. doi: 10.1016/j.jneuroim.2019.03.018. Epub 2019 Mar 29.

Abstract

In our study, we assessed the potency of the brain-derived proteins ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), matrix metalloproteinase 9 (MMP-9), glial fibrillary acidic protein (GFAP) and the immune activation indicators interleukin 1β (IL-1β) and interleukin 6 (IL-6) as peripheral biomarkers of different susceptibilities to kindling in a preclinical model. We observed increased plasma UCH-L1 levels in kindled vs. control animals. Furthermore, MMP-9 and IL-1β concentrations were the lowest in rats resistant to kindling. In summary, UCH-L1 is an indicator of neuronal loss and BBB disruption after seizure. MMP-9 and IL-1β may indicate resistance to kindling. UCH-L1, MMP-9 and IL-1β may have utility as peripheral biomarkers with translational potency in the clinic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers
  • Brain Chemistry*
  • Convulsants / toxicity
  • Disease Susceptibility
  • Glial Fibrillary Acidic Protein / blood*
  • Interleukin-1beta / blood
  • Interleukin-6 / blood
  • Kindling, Neurologic / drug effects
  • Kindling, Neurologic / metabolism
  • Male
  • Matrix Metalloproteinase 9 / blood*
  • Models, Animal
  • Pentylenetetrazole / toxicity
  • Rats
  • Rats, Wistar
  • Seizures / blood*
  • Seizures / chemically induced
  • Ubiquitin Thiolesterase / blood*

Substances

  • Biomarkers
  • Convulsants
  • GFAP protein, rat
  • Glial Fibrillary Acidic Protein
  • Il6 protein, rat
  • Interleukin-1beta
  • Interleukin-6
  • UCHL1 protein, rat
  • Ubiquitin Thiolesterase
  • Matrix Metalloproteinase 9
  • Pentylenetetrazole